(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are Itau Unibanco, DraftKings, and DouYu.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Itau Unibanco (ITUB) | 5.51 | 3.18% | 2023-05-22 04:41:34 |
| 2 | DraftKings (DKNG) | 24.85 | 3.07% | 2023-05-22 07:13:44 |
| 3 | DouYu (DOYU) | 1.06 | 2.77% | 2023-05-22 07:13:49 |
| 4 | Gevo (GEVO) | 1.19 | 2.53% | 2023-05-22 07:09:47 |
| 5 | SmileDirectClub (SDC) | 0.36 | 2.02% | 2023-05-22 04:29:54 |
| 6 | NeuroMetrix (NURO) | 1.01 | 1.57% | 2023-05-22 04:35:57 |
| 7 | Futu Holdings (FUTU) | 38.67 | 1.52% | 2023-05-22 07:13:57 |
| 8 | Banco Santander (SAN) | 3.47 | 1.46% | 2023-05-22 04:44:28 |
| 9 | QuantumScape (QS) | 6.10 | 0.99% | 2023-05-22 04:47:14 |
| 10 | Deutsche Bank (DB) | 10.69 | 0.86% | 2023-05-22 07:17:16 |
The three biggest losers today are FibroGen, Redfin, and AmerisourceBergen.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | FibroGen (FGEN) | 17.00 | -3.24% | 2023-05-22 07:09:24 |
| 2 | Redfin (RDFN) | 10.12 | -1.94% | 2023-05-22 07:14:42 |
| 3 | AmerisourceBergen (ABC) | 170.06 | -1.92% | 2023-05-22 07:15:43 |
| 4 | AmerisourceBergen (ABC) | 170.06 | -1.92% | 2023-05-22 07:15:43 |
| 5 | Inovio Pharmaceuticals (INO) | 0.66 | -1.46% | 2023-05-22 07:10:21 |
| 6 | Nikola (NKLA) | 0.75 | -1.41% | 2023-05-22 07:14:24 |
| 7 | Identiv (INVE) | 7.47 | -0.93% | 2023-05-22 04:10:41 |
| 8 | Vodafone (VOD) | 10.28 | -0.66% | 2023-05-22 07:12:42 |
| 9 | Cincinnati Financial (CINF) | 104.44 | -0.5% | 2023-05-22 04:08:23 |
| 10 | Lloyds Banking Group (LYG) | 2.31 | -0.43% | 2023-05-22 04:42:17 |
Premarket Winners today
1. Itau Unibanco (ITUB) – Premarket: 3.18%
Itaú Unibanco Holding S.A. offers a range of financial products and services to individuals and corporate customers in Brazil and internationally. The company operates through three segments: Retail Banking, Wholesale Banking, and Activities with the Market + Corporation. It offers current account; loans; credit and debit cards; investment and commercial banking services; real estate lending services; financing and investment services; economic, financial and brokerage advisory; and leasing and foreign exchange services. The company also provides property and casualty insurance products covering loss, damage, or liabilities for assets or persons, as well as life insurance products covering death and personal accident. It serves retail customers, account and non-account holders, individuals and legal entities, high income clients, microenterprises, and small companies, as well as middle-market companies and high net worth clients. The company was formerly known as Itaú Unibanco Banco Múltiplo S.A. and changed its name to Itaú Unibanco Holding S.A. in April 2009. The company was incorporated in 1924 and is headquartered in São Paulo, Brazil. Itaú Unibanco Holding S.A. is a subsidiary of IUPAR – Itaú Unibanco Participações S.A.
NYSE ended the session with Itau Unibanco sliding 1.57% to $5.34 on Monday, after two consecutive sessions in a row of losses. NYSE slid 0.14% to $15,324.32, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, Itau Unibanco has a trailing twelve months EPS of $0.61.
PE Ratio
Itau Unibanco has a trailing twelve months price to earnings ratio of 8.76. Meaning, the purchaser of the share is investing $8.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.18%.
Yearly Top and Bottom Value
Itau Unibanco’s stock is valued at $5.34 at 08:34 EST, way below its 52-week high of $6.07 and way above its 52-week low of $3.90.
Volatility
Itau Unibanco’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.70%, a positive 0.24%, and a positive 1.90%.
Itau Unibanco’s highest amplitude of average volatility was 1.44% (last week), 1.29% (last month), and 1.90% (last quarter).
More news about Itau Unibanco.
2. DraftKings (DKNG) – Premarket: 3.07%
DraftKings Inc. operates a digital sports entertainment and gaming company. It offers multi-channel sports betting and gaming technologies, powering sports and gaming entertainment for operators in 17 countries. The company operates iGaming through its DraftKings brand in 5 states, as well as operates Golden Nugget Online Gaming, an iGaming product and gaming brand in 3 states. Its Sportsbook is live with mobile and/or retail betting operations in the United States pursuant to regulations in 18 states. The company's daily fantasy sports product is available in 6 countries internationally with 15 distinct sports categories. In addition, it offers DraftKings Marketplace, a digital collectibles ecosystem designed for mainstream accessibility that offers curated NFT drops and supports secondary-market transactions, as well as owns Vegas Sports Information Network (VSiN), a multi-platform broadcast and content company. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
NASDAQ ended the session with DraftKings jumping 0.56% to $24.11 on Monday, after two sequential sessions in a row of gains. NASDAQ fell 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, DraftKings has a trailing twelve months EPS of $-2.76.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -108.8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
DraftKings’s EBITDA is 4.38.
More news about DraftKings.
3. DouYu (DOYU) – Premarket: 2.77%
DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors professional players and teams, and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.
NASDAQ ended the session with DouYu sliding 0.49% to $1.03 on Monday, following the last session’s downward trend. NASDAQ fell 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, DouYu has a trailing twelve months EPS of $-0.04.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.41%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
DouYu’s EBITDA is 9.55.
More news about DouYu.
4. Gevo (GEVO) – Premarket: 2.53%
Gevo, Inc. operates as a renewable fuels company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company offers renewable gasoline and diesel, isooctane, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with Gevo dropping 3.75% to $1.16 on Monday, following the last session’s downward trend. NASDAQ fell 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Gevo has a trailing twelve months EPS of $-0.44.
Moving Average
Gevo’s value is way under its 50-day moving average of $1.40 and way below its 200-day moving average of $2.10.
Sales Growth
Gevo’s sales growth is 3641.6% for the present quarter and 175.4% for the next.
Volatility
Gevo’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.55%, a negative 0.02%, and a positive 4.27%.
Gevo’s highest amplitude of average volatility was 5.09% (last week), 4.68% (last month), and 4.27% (last quarter).
Yearly Top and Bottom Value
Gevo’s stock is valued at $1.16 at 08:34 EST, way under its 52-week high of $4.81 and way above its 52-week low of $1.01.
More news about Gevo.
5. SmileDirectClub (SDC) – Premarket: 2.02%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub dropping 1.34% to $0.35 on Monday, after two successive sessions in a row of losses. NASDAQ slid 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.
Volatility
SmileDirectClub’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.30%, a negative 0.85%, and a positive 4.46%.
SmileDirectClub’s highest amplitude of average volatility was 4.55% (last week), 3.72% (last month), and 4.46% (last quarter).
Sales Growth
SmileDirectClub’s sales growth is negative 19% for the current quarter and 10.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 31.5%, now sitting on 470.74M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 35.3% and 55.6%, respectively.
More news about SmileDirectClub.
6. NeuroMetrix (NURO) – Premarket: 1.57%
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix dropping 0.37% to $0.99 on Monday, after three successive sessions in a row of gains. NASDAQ dropped 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.62.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.76%.
More news about NeuroMetrix.
7. Futu Holdings (FUTU) – Premarket: 1.52%
Futu Holdings Limited provides digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. It offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. The company also provides financial information and online community services; online wealth management services under the brand of Money Plus through its Futubull and moomoo platforms, which give access to mutual funds, private funds, and bonds; market data and information services; and NiuNiu Community, which serves as an open forum for users and clients to share insights, ask questions, and exchange ideas. In addition, the company provides initial public offering subscription and employee share option plan solution services. Futu Holdings Limited was founded in 2007 and is based in Hong Kong, Hong Kong.
NASDAQ ended the session with Futu Holdings falling 1.47% to $38.09 on Monday while NASDAQ dropped 0.24% to $12,657.90.
Earnings Per Share
As for profitability, Futu Holdings has a trailing twelve months EPS of $2.62.
PE Ratio
Futu Holdings has a trailing twelve months price to earnings ratio of 14.54. Meaning, the purchaser of the share is investing $14.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.99%.
Sales Growth
Futu Holdings’s sales growth is 24.4% for the present quarter and 12.9% for the next.
Yearly Top and Bottom Value
Futu Holdings’s stock is valued at $38.09 at 08:34 EST, way below its 52-week high of $72.20 and way higher than its 52-week low of $28.00.
More news about Futu Holdings.
8. Banco Santander (SAN) – Premarket: 1.46%
Banco Santander, S.A. provides various retail and commercial banking products and services to individuals, small and medium-sized enterprises, and large companies worldwide. The company operates through Retail Banking, Santander Corporate & Investment Banking, Wealth Management & Insurance, and PagoNxt segments. It offers demand and time deposits, and current and savings accounts; mortgages, consumer finance, syndicated corporate loans, cash management, export and agency finance, trade and working capital solutions, and corporate finance; and insurance products. The company also provides cash, asset, and wealth management; and private banking services. In addition, it is involved in the corporate banking, treasury, risk hedging, foreign trade, and investment banking activities, as well as provides digital payment solutions. The company was formerly known as Banco Santander Central Hispano S.A. and changed its name to Banco Santander, S.A. in June 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.
NYSE ended the session with Banco Santander dropping 0.15% to $3.42 on Monday while NYSE dropped 0.14% to $15,324.32.
Earnings Per Share
As for profitability, Banco Santander has a trailing twelve months EPS of $0.59.
PE Ratio
Banco Santander has a trailing twelve months price to earnings ratio of 5.79. Meaning, the purchaser of the share is investing $5.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.82%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 3.57%.
Moving Average
Banco Santander’s worth is under its 50-day moving average of $3.65 and way above its 200-day moving average of $3.07.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Santander’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 41.72B for the twelve trailing months.
More news about Banco Santander.
9. QuantumScape (QS) – Premarket: 0.99%
QuantumScape Corporation, a development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. QuantumScape Corporation was founded in 2010 and is headquartered in San Jose, California.
NYSE ended the session with QuantumScape dropping 2.42% to $6.04 on Monday while NYSE fell 0.14% to $15,324.32.
Earnings Per Share
As for profitability, QuantumScape has a trailing twelve months EPS of $-1.05.
Volatility
QuantumScape’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.45%, a negative 1.44%, and a positive 3.14%.
QuantumScape’s highest amplitude of average volatility was 2.45% (last week), 3.05% (last month), and 3.14% (last quarter).
Volume
Today’s last reported volume for QuantumScape is 2597580 which is 43.03% below its average volume of 4559820.
More news about QuantumScape.
10. Deutsche Bank (DB) – Premarket: 0.86%
Deutsche Bank Aktiengesellschaft, operates as a stock corporation, engages in the provision of corporate and investment banking, and asset management products and services to private clients, corporate entities, and institutional clients worldwide. Its Corporate Bank segment provides cash management, trade finance and lending, trust and agency, foreign exchange, and securities services, as well as risk management solutions. The company's Investment Bank segment offers debt origination, merger and acquisitions, and equity advisory services. Its Private Bank segment provides payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management services, postal and parcel services; and offers support in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The company's Asset Management segment provides investment solutions, such as alternative investments, which include real estate, infrastructure, private equity, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is based in Frankfurt am Main, Germany.
NYSE ended the session with Deutsche Bank rising 0.14% to $10.60 on Monday, after two successive sessions in a row of gains. NYSE fell 0.14% to $15,324.32, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Deutsche Bank has a trailing twelve months EPS of $2.64.
PE Ratio
Deutsche Bank has a trailing twelve months price to earnings ratio of 4.01. Meaning, the purchaser of the share is investing $4.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.1%.
Yearly Top and Bottom Value
Deutsche Bank’s stock is valued at $10.60 at 08:34 EST, way under its 52-week high of $13.57 and way above its 52-week low of $7.25.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.9%, now sitting on 26.26B for the twelve trailing months.
Volume
Today’s last reported volume for Deutsche Bank is 1625790 which is 66.93% below its average volume of 4916780.
Volatility
Deutsche Bank’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.05%, a positive 0.22%, and a positive 2.09%.
Deutsche Bank’s highest amplitude of average volatility was 0.82% (last week), 1.56% (last month), and 2.09% (last quarter).
More news about Deutsche Bank.
Premarket Losers Today
1. FibroGen (FGEN) – Premarket: -3.24%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen dropping 0.43% to $17.57 on Monday while NASDAQ fell 0.24% to $12,657.90.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-3.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -411.93%.
Volume
Today’s last reported volume for FibroGen is 493129 which is 45.67% below its average volume of 907737.
Revenue Growth
Year-on-year quarterly revenue growth declined by 40.6%, now sitting on 116.07M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FibroGen’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
FibroGen’s stock is valued at $17.57 at 08:34 EST, way under its 52-week high of $25.69 and way above its 52-week low of $8.15.
More news about FibroGen.
2. Redfin (RDFN) – Premarket: -1.94%
Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Redfin sliding 4.13% to $10.32 on Monday, following the last session’s downward trend. NASDAQ dropped 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Redfin has a trailing twelve months EPS of $-2.72.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -173.25%.
Moving Average
Redfin’s worth is way above its 50-day moving average of $8.39 and way higher than its 200-day moving average of $7.08.
More news about Redfin.
3. AmerisourceBergen (ABC) – Premarket: -1.92%
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
NYSE ended the session with AmerisourceBergen falling 0.82% to $173.39 on Monday while NYSE fell 0.14% to $15,324.32.
Earnings Per Share
As for profitability, AmerisourceBergen has a trailing twelve months EPS of $7.8.
PE Ratio
AmerisourceBergen has a trailing twelve months price to earnings ratio of 22.23. Meaning, the purchaser of the share is investing $22.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 221.04%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AmerisourceBergen’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 247.54B for the twelve trailing months.
More news about AmerisourceBergen.
4. AmerisourceBergen (ABC) – Premarket: -1.92%
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
NYSE ended the session with AmerisourceBergen falling 0.82% to $173.39 on Monday, following the last session’s downward trend. NYSE slid 0.14% to $15,324.32, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, AmerisourceBergen has a trailing twelve months EPS of $7.8.
PE Ratio
AmerisourceBergen has a trailing twelve months price to earnings ratio of 22.23. Meaning, the purchaser of the share is investing $22.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 221.04%.
Sales Growth
AmerisourceBergen’s sales growth is 5.7% for the present quarter and 6.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 247.54B for the twelve trailing months.
Moving Average
AmerisourceBergen’s worth is above its 50-day moving average of $161.55 and way higher than its 200-day moving average of $156.35.
Volatility
AmerisourceBergen’s last week, last month’s, and last quarter’s current intraday variation average was 0.01%, 0.20%, and 0.86%.
AmerisourceBergen’s highest amplitude of average volatility was 0.42% (last week), 0.65% (last month), and 0.86% (last quarter).
More news about AmerisourceBergen.
5. Inovio Pharmaceuticals (INO) – Premarket: -1.46%
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
NASDAQ ended the session with Inovio Pharmaceuticals jumping 3.4% to $0.67 on Monday, following the last session’s upward trend. NASDAQ slid 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.12.
Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $0.67 at 08:34 EST, way below its 52-week high of $2.82 and higher than its 52-week low of $0.64.
Moving Average
Inovio Pharmaceuticals’s value is way under its 50-day moving average of $0.86 and way under its 200-day moving average of $1.62.
More news about Inovio Pharmaceuticals.
6. Nikola (NKLA) – Premarket: -1.41%
Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola jumping 2.3% to $0.76 on Monday while NASDAQ slid 0.24% to $12,657.90.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.71.
Sales Growth
Nikola’s sales growth is negative 16.7% for the current quarter and 37.9% for the next.
Yearly Top and Bottom Value
Nikola’s stock is valued at $0.76 at 08:34 EST, below its 52-week low of $0.76.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 12% and 35.7%, respectively.
Volatility
Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.05%, a negative 1.08%, and a positive 5.40%.
Nikola’s highest amplitude of average volatility was 3.73% (last week), 4.92% (last month), and 5.40% (last quarter).
More news about Nikola.
7. Identiv (INVE) – Premarket: -0.93%
Identiv, Inc. operates as a security technology company that secures things, data, and physical places in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Identity and Premises. The Identity segment offers products and solutions that enables secure access to information serving the logical access and cyber security markets, as well as protecting connected objects and information using radio-frequency identification embedded security. The Premises segment provides solutions for premises security market, such as access control, video surveillance, analytics, audio, access readers, and identities to government facilities, schools, utilities, hospitals, stores, and apartment buildings. The company sells its products through dealers, systems integrators, value added resellers, and resellers. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California.
NASDAQ ended the session with Identiv jumping 1.07% to $7.54 on Monday, after five successive sessions in a row of gains. NASDAQ dropped 0.24% to $12,657.90, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Identiv has a trailing twelve months EPS of $-0.14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.87%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Identiv’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Identiv’s stock is valued at $7.54 at 08:34 EST, way below its 52-week high of $16.98 and way above its 52-week low of $5.07.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 113.85M for the twelve trailing months.
Volume
Today’s last reported volume for Identiv is 50294 which is 54.79% below its average volume of 111248.
More news about Identiv.
8. Vodafone (VOD) – Premarket: -0.66%
Vodafone Group Public Limited Company engages in telecommunication services in Europe and internationally. The company offers mobile services that enable customers to call, text, and access data; fixed line services, including broadband, television (TV) offerings, and voice; and convergence services under the GigaKombi and Vodafone One names to customers. It also provides value added services, such as Internet of Things (IoT) comprising logistics and fleet management, smart metering, insurance, cloud, and security services; and automotive and health solutions. In addition, the company offers M-Pesa, an African payment platform, which provides money transfer, financial, and business and merchant payment services; and various services to operators through its partner market agreements. Vodafone Group Public Limited Company has a strategic partnership with Open Fiber. The company was incorporated in 1984 and is based in Newbury, the United Kingdom.
NASDAQ ended the session with Vodafone jumping 0.93% to $10.35 on Monday while NASDAQ slid 0.24% to $12,657.90.
Earnings Per Share
As for profitability, Vodafone has a trailing twelve months EPS of $0.79.
PE Ratio
Vodafone has a trailing twelve months price to earnings ratio of 13.09. Meaning, the purchaser of the share is investing $13.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.47%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Vodafone’s stock is considered to be oversold (<=20).
More news about Vodafone.
9. Cincinnati Financial (CINF) – Premarket: -0.5%
Cincinnati Financial Corporation, together with its subsidiaries, provides property casualty insurance products in the United States. The company operates through five segments: Commercial Lines Insurance, Personal Lines Insurance, Excess and Surplus Lines Insurance, Life Insurance, and Investments. The Commercial Lines Insurance segment offers coverage for commercial casualty, commercial property, commercial auto, and workers' compensation. It also provides director and officer liability insurance, contract and commercial surety bonds, and fidelity bonds; and machinery and equipment coverage. The Personal Lines Insurance segment offers personal auto insurance; homeowner insurance; and dwelling fire, inland marine, personal umbrella liability, and watercraft coverages to individuals. The Excess and Surplus Lines Insurance segment offers commercial casualty insurance that covers businesses for third-party liability from accidents occurring on their premises or arising out of their operations, such as injuries sustained from products; and commercial property insurance, which insures buildings, inventory, equipment, and business income from loss or damage due to various causes, such as fire, wind, hail, water, theft, and vandalism. The Life Insurance segment provides term life insurance products; universal life insurance products; worksite products, such as term life; and whole life insurance products. The Investments segment invests in fixed-maturity investments, including taxable and tax-exempt bonds, and redeemable preferred stocks; and equity investments comprising common and nonredeemable preferred stocks. It also offers commercial leasing and financing services; and insurance brokerage services. Cincinnati Financial Corporation was founded in 1950 and is headquartered in Fairfield, Ohio.
NASDAQ ended the session with Cincinnati Financial dropping 0.73% to $104.96 on Monday while NASDAQ dropped 0.24% to $12,657.90.
Earnings Per Share
As for profitability, Cincinnati Financial has a trailing twelve months EPS of $0.02.
PE Ratio
Cincinnati Financial has a trailing twelve months price to earnings ratio of 5248. Meaning, the purchaser of the share is investing $5248 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.04%.
More news about Cincinnati Financial.
10. Lloyds Banking Group (LYG) – Premarket: -0.43%
Lloyds Banking Group plc, together with its subsidiaries, provides a range of banking and financial services in the United Kingdom. It operates through three segments: Retail; Commercial Banking; and Insurance, Pensions, and Investments. The Retail segment offers a range of financial service products, including current accounts, savings, mortgages, motor finance, unsecured loans, leasing solutions, and credit cards to personal and small business customers. The Commercial Banking segment provides lending, transactional banking, working capital management, risk management, and debt financing services to small and medium-sized entities, corporates, and institutions. The Insurance, Pensions, and Investments segment offers insurance, investment, and pension management products and services. It also provides digital banking services. The company offers its products and services under the Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows brands. Lloyds Banking Group plc was founded in 1695 and is based in London, the United Kingdom.
NYSE ended the session with Lloyds Banking Group rising 1.31% to $2.32 on Monday, following the last session’s upward trend. NYSE fell 0.14% to $15,324.32, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Lloyds Banking Group has a trailing twelve months EPS of $0.4.
PE Ratio
Lloyds Banking Group has a trailing twelve months price to earnings ratio of 5.8. Meaning, the purchaser of the share is investing $5.8 for every dollar of annual earnings.
Moving Average
Lloyds Banking Group’s value is below its 50-day moving average of $2.34 and higher than its 200-day moving average of $2.22.
More news about Lloyds Banking Group.
Stay up to date with our premarket winners and losers daily report
